Consequently, circANRIL induced nucleolar stress and p53 activation resulting in induction of apoptosis and inhibition of the cell cycle, which would be expected to confer protection against the development of atheroma, and also tumour development [15]. This evidence concerns the gene TP53 and neoplasm.